For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Rockwell Medical Inc (NASDAQ: RMTI) was $1.29 for the day, up 8.40% from the previous closing price of $1.19. In other words, the price has increased by $8.40 from its previous closing price. On the day, 1.84 million shares were traded. RMTI stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.2548.
Ratios:
Our analysis of RMTI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.41. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 01 ’25 when Chole Timothy sold 2,868 shares for $0.82 per share. The transaction valued at 2,352 led to the insider holds 128,167 shares of the business.
Neri Jesse sold 886 shares of RMTI for $727 on Jul 01 ’25. The SVP and CFO now owns 126,614 shares after completing the transaction at $0.82 per share. On Jul 01 ’25, another insider, Strobeck Mark, who serves as the President and CEO of the company, sold 6,926 shares for $0.82 each. As a result, the insider received 5,679 and left with 337,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 47906340 and an Enterprise Value of 24517134. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.45 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 0.251 whereas that against EBITDA is 8.928.
Stock Price History:
The Beta on a monthly basis for RMTI is 1.61, which has changed by -0.3943662 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is 30.03%, while the 200-Day Moving Average is calculated to be -34.30%.
Shares Statistics:
RMTI traded an average of 243.79K shares per day over the past three months and 591680 shares per day over the past ten days. A total of 34.26M shares are outstanding, with a floating share count of 28.72M. Insiders hold about 15.97% of the company’s shares, while institutions hold 20.38% stake in the company. Shares short for RMTI as of 1749772800 were 168973 with a Short Ratio of 0.69, compared to 1747267200 on 191155. Therefore, it implies a Short% of Shares Outstanding of 168973 and a Short% of Float of 0.5599999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $16.79M to a low estimate of $15.87M. As of the current estimate, Rockwell Medical Inc’s year-ago sales were $25.83MFor the next quarter, 2 analysts are estimating revenue of $16.01M. There is a high estimate of $16.67M for the next quarter, whereas the lowest estimate is $15.35M.
A total of 2 analysts have provided revenue estimates for RMTI’s current fiscal year. The highest revenue estimate was $69.62M, while the lowest revenue estimate was $66.84M, resulting in an average revenue estimate of $68.23M. In the same quarter a year ago, actual revenue was $101.49MBased on 2 analysts’ estimates, the company’s revenue will be $75.84M in the next fiscal year. The high estimate is $81.51M and the low estimate is $70.18M.
